Hypertriglyceridemia.
Brahm A, Hegele RA.
Nutrients. 2013 Mar 22;5(3):981-1001. doi: 10.3390/nu5030981.
Emerging agents targeting triglycerides.
Prakash Y, Bhatt DL, Malick WA.
Curr Opin Lipidol. 2025 Jun 1;36(3):119-129. doi: 10.1097/MOL.0000000000000979. Epub 2025 Feb 18.
The spectrum of type III hyperlipoproteinemia.
Sniderman AD, de Graaf J, Thanassoulis G, Tremblay AJ, Martin SS, Couture P.
J Clin Lipidol. 2018 Nov-Dec;12(6):1383-1389. doi: 10.1016/j.jacl.2018.09.006. Epub 2018 Sep 14.
Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE.
Yesiltepe M, Yin T, Tambini M, Bao H, Pan M, d'Abramo C, Giliberto L, Han X, D'Adamio L.
Cell Commun Signal. 2024 Sep 27;22(1):458. doi: 10.1186/s12964-024-01832-2.
The clinical and laboratory investigation of dysbetalipoproteinemia.
Boot CS, Luvai A, Neely RDG.
Crit Rev Clin Lab Sci. 2020 Nov;57(7):458-469. doi: 10.1080/10408363.2020.1745142. Epub 2020 Apr 7.
Umbrella Review on Non-Statin Lipid-Lowering Therapy.
Beshir SA, Hussain N, Elnor AA, Said ASA.
J Cardiovasc Pharmacol Ther. 2021 Sep;26(5):437-452. doi: 10.1177/10742484211002943. Epub 2021 Apr 9.
Phytosterols, Phytostanols, and Lipoprotein Metabolism.
Gylling H, Simonen P.
Nutrients. 2015 Sep 17;7(9):7965-77. doi: 10.3390/nu7095374.
Risk of Chronic Disease after an Episode of Marasmus, Kwashiorkor or Mixed-Type Severe Acute Malnutrition in the Democratic Republic of Congo: The Lwiro Follow-Up Study.
Mwene-Batu P, Bisimwa G, Donnen P, Bisimwa J, Tshongo C, Dramaix M, Hermans MP, Briend A.
Nutrients. 2022 Jun 14;14(12):2465. doi: 10.3390/nu14122465.
The Treatment of Disorders of Lipid Metabolism.
Parhofer KG.
Dtsch Arztebl Int. 2016 Apr 15;113(15):261-8. doi: 10.3238/arztebl.2016.0261.
MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists.
Cooreman MP, Vonghia L, Francque SM.
Diabetes Res Clin Pract. 2024 Jun;212:111688. doi: 10.1016/j.diabres.2024.111688. Epub 2024 May 1.
